NCT04748224View on ClinicalTrials.gov

Dexmedetomidine as an Adjuvant to Local Anesthesia in Quadratus Lumborum Block After Cesarean Delivery

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 2, 2020

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
Anesthesia, Local
Interventions
DRUG

Bupivacaine 0.25% Injectable Solution

a local anesthetic drug

DRUG

bupivacaine plus dexmedetomidine

bupivacaine is a local anesthetic drug plus dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR) agonist that is associated with sedative and analgesic sparing effects

Trial Locations (2)

11956

Faculty of Medicine Cairo University, Cairo

Faculty of Medicine, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04748224 - Dexmedetomidine as an Adjuvant to Local Anesthesia in Quadratus Lumborum Block After Cesarean Delivery | Biotech Hunter | Biotech Hunter